Healthcare

Certify Releases Blueprint Report for Provider Credentialing Automation

Findings show that automated data acquisition and system integration enhance provider data accuracy, reduce administrative costs, and enhance patient care…

6 months ago

Axxess 2025 AGILE Conference to be held May 5-7 in Dallas

DALLAS, July 18, 2024 /PRNewswire/ -- Axxess, the leading global technology innovator for healthcare at home, today announced the 2025…

6 months ago

Eyenuk Appoints Bryan Haardt as Chief Executive Officer

Haardt brings decades of digital healthcare experience to build on Eyenuk's global mission of using AI to detect and prevent…

6 months ago

Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer’s biosimilar to Humira®

First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18,…

6 months ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning

Webcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation…

6 months ago

Therma Bright Engages Independent Trading Group as Market Maker

Toronto, Ontario--(Newsfile Corp. - July 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the…

6 months ago

ADIA Nutrition Inc. Announces Restructuring, Unveiling Two Dynamic Divisions

Winter Park, Florida--(Newsfile Corp. - July 18, 2024) - ADIA Nutrition Inc., (OTC Pink: ADIA) proudly announces a strategic restructuring…

6 months ago

InnovaCare Health Welcomes Kat Alvarez as Chief Strategy Officer

Alvarez will focus on strategic development in the healthcare ecosystem to drive access to high-quality healthcare as the risk-bearing organization…

6 months ago

Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology…

6 months ago

Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery

‘Breaking Barriers’ Coalition Formed to Address Opioid Use Disorder in the USA Nexalin CEO Mark White Participates in Inaugural Meeting…

6 months ago